{"schema_version":"secwatch.filing_event.v1","accession":"0000927653-22-000074","form_type":"8-K","ticker":"MCK","cik":"0000927653","company_name":"MCKESSON CORP","filed_at":"2022-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.681365+00:00","generated_at":"2026-06-24T05:37:46.745361+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"McKesson Q1 adj EPS $5.83, revenue $67.2B; raises FY2023 outlook to $23.95-$24.65","bullets":["Adjusted EPS $5.83 vs $5.56 (+5%); GAAP EPS $5.25 vs $3.09 (+70%).","Revenue $67.2B, up 7% YoY, driven by U.S. pharmaceutical and specialty distribution.","FY2023 adjusted EPS guidance raised to $23.95-$24.65 from $22.90-$23.60.","Core adjusted EPS growth (ex-COVID programs) forecasted at 10-15% for fiscal 2023.","Guidance includes COVID vaccine distribution contribution of $0.35-$0.45 and ancillary supplies/testing of $0.75-$0.95 per share."],"urls":{"canonical":"https://secwatch.observer/filing/0000927653-22-000074","json":"https://secwatch.observer/filing/0000927653-22-000074.json","markdown":"https://secwatch.observer/filing/0000927653-22-000074.md","text":"https://secwatch.observer/filing/0000927653-22-000074.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/927653/000092765322000074/0000927653-22-000074-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/927653/000092765322000074/mck-20220803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T05:37:46.745361+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}